March 6, 2009 - American College of Cardiology’s (ACC) President W. Douglas Weaver, M.D., participated in yesterday’s White House Summit on Health Care and released the following comments:
March 6, 2009 – At the ECR congress, Barco unveiled an upgraded version of the Nio Color 3MP diagnostic display system, featuring a high-bright LCD panel.
March 5, 2009 - In the first six-year follow-up of a pivotal study of any drug-eluting stent, the clinical benefits of the CYPHER Sirolimus-eluting Coronary Stent compared to a bare-metal stent (BMS) were sustained according to data presented at the Cardiovascular Revascularization Therapies conference.
March 5, 2009 - During the Best Peer Practice "Achieve Measurable Results Through CVIS" Webinar, attendees will learn how to use CVIS data to support quality initiatives and provide instant feedback on performance.
March 5, 2009 - CorMatrix Cardiovascular Inc., developer of extracellular matrix (ECM Technology) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced the first implant in Europe of the CorMatrix ECM Technology in a patient undergoing cardiac surgery.
March 5, 2009 - TomTec is showcasing its brand-new CardioArena multimodality workstation for Cardio PACS during the upcoming ECR conference in Vienna, Austria.
The CardioArena platform is a commercially available solution for 2D, 3D, and 4D imaging data. It serves multimodality platform for all major medical imaging modalities such as ultrasound, MRI and cathlab.
March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first phase of its first-in-human clinical trial for the vProtect Luminal Shield, conducted at the Corbic Research Institute in Colombia.
March 5, 2009 - Patients with chronic kidney disease who also suffer from atrial fibrillation (AF) are at increased risk for stroke, according to a new study by Kaiser Permanente researchers in the current online issue of Circulation.
March 5, 2009 - Reducing the frequency and severity of disabling migraines is crucial for quality of life and a new study, published in the February 2009 issue of JACC: Cardiovascular Interventions, finds significant improvement of migraines following catheter-based closure of patent foramen ovale (PFO).